NYVO
Live / Applied — Second extension granted (statement of use) (as of 24 Feb 2026)
What this means for you
Not registered yet, but its 18 Jun 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98606971
- Mark type
- Stylized text
- Filed
- 18 Jun 2024
- Published for opposition
- 21 Jan 2025
- Attorney of record
- Christopher Turk
Goods and services
- Class 005 — Pharmaceuticals: medicines and pharmaceutical preparations for the treatment of amyotrophic lateral sclerosis (als); medicines and pharmaceutical preparations for the treatment of neurodegenerative diseases; medicines and pharmaceutical preparations for the treatment of central nervous system and peripheral nervous system diseases and disorders; medicines and pharmaceutical preparations for the treatment of viral diseases; medicines and pharmaceutical preparations for the treatment of immune system related diseases and disorders; medicines and pharmaceutical preparations for the treatment of innate immune system related diseases and disorders
Owner
- Neuvivo, Inc., Palo Alto, CA, US
- Neuvivo, Inc., Palo Alto, CA, US
Prosecution history
- 25 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Feb 2026 — SOU EXTENSION 2 GRANTED
- 24 Feb 2026 — SOU EXTENSION 2 FILED
- 24 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 21 Feb 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 21 Feb 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 21 Feb 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 12 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Sept 2025 — SOU EXTENSION 1 GRANTED
- 11 Sept 2025 — SOU EXTENSION 1 FILED
- 11 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 18 Mar 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 21 Jan 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 21 Jan 2025 — PUBLISHED FOR OPPOSITION
- 15 Jan 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED